Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Fibrosis × Hyperbaric Oxygenation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Radiation Fibrosis Syndrome 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Complications 1 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma 1 Lymphedema 1 Laryngeal Neoplasms 1 Hodgkin Disease 1 Gliosarcoma 1 Glioblastoma 1 Fibrosis 1

Interventions

Pentoxifylline 3 Tocopherols 2 tremelimumab 1 ruxolitinib 1 maltodextrin 1 durvalumab 1 atezolizumab 1 Vitamin E 1 Sunitinib 1 Standard of Care 1 Specimen Handling 1 Simvastatin 1 Pravastatin 1 Physical Therapy Modalities 1 Pharmaceutical Preparations 1 Magnetic Resonance Spectroscopy 1 Losartan 1 Liver Transplantation 1 Ketoprofen 1 Hyperbaric Oxygenation 1 Bevacizumab 1 Amino Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01822405 2013-04-02

ORT-OXI-2009

Hospital Universitario de Canarias

Phase 2 Unknown

Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡